UNITED THERAPEUTICS Corp (UTHR) › Operating IncomeUNITED THERAPEUTICS Corp (UTHR) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2008: -$82.06M2009: $25.76M2010: $171.31M2011: $317.78M2012: $421.65M2013: $292.50M2014: $538.80M2015: $699.00M2016: $1.06B2017: $814.90M2018: $805.40M2019: -$187.60M2020: $593.60M2021: $555.90M2022: $979.70M2023: $1.18B2024: $1.38B2025: $1.49B$1.49B2008Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025$1.49B+8.4%2024$1.38B+16.2%2023$1.18B+20.9%2022$979.70M+76.2%2021$555.90M-6.4%2020$593.60M+416.4%2019-$187.60M-123.3%2018$805.40M-1.2%2017$814.90M-23.2%2016$1.06B+51.9%2015$699.00M+29.7%2014$538.80M+84.2%2013$292.50M-30.6%2012$421.65M+32.7%2011$317.78M+85.5%2010$171.31M+565.1%2009$25.76M+131.4%2008-$82.06M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share